AZN
AstraZeneca PLC
Balance sheet
| USDLine, in USD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.71B | 5.49B | 5.84B | 6.17B | 6.33B | 7.83B | 5.37B | 4.83B | 3.32B | 5.02B | 6.24B | |
Inventory | 6.56B | 5.29B | 5.42B | 4.70B | 8.98B | 4.02B | 3.19B | 2.89B | 3.04B | 2.33B | 2.14B |
| Current assets | 28.7B | 25.8B | 25.1B | 22.6B | 26.2B | 19.5B | 15.6B | 15.6B | 13.2B | 13.3B | 16.0B |
Goodwill | 21.2B | 21.0B | 20.0B | 19.8B | 20.0B | 11.8B | 11.7B | 11.7B | 11.8B | 11.7B | 11.8B |
Intangible assets | 37.8B | 37.2B | 38.1B | 39.3B | 42.5B | 20.9B | 20.8B | 22.0B | 26.2B | 27.6B | 22.6B |
| Total assets | 114.1B | 104.0B | 101.1B | 96.5B | 105.4B | 66.7B | 61.4B | 60.7B | 63.4B | 62.5B | 60.1B |
Current liabilities | 30.6B | 27.9B | 30.5B | 26.3B | 22.6B | 20.3B | 18.1B | 16.3B | 16.4B | 15.3B | 14.9B |
| 24.7B | 26.5B | 22.4B | 23.0B | 28.1B | 17.5B | 15.7B | 17.4B | 15.6B | 14.5B | 14.1B | |
| Total liabilities | 65.4B | 63.2B | 62.0B | 59.4B | 66.1B | 51.1B | 46.8B | 46.6B | 46.7B | 45.9B | 41.5B |
| Shareholders' equity | 48.7B | 40.8B | 39.1B | 37.0B | 39.3B | 15.6B | 13.1B | 12.5B | 15.0B | 14.9B | 18.5B |
| Current ratio | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | 0.86 | 0.96 | 0.80 | 0.87 | 1.08 |